I hold two graduate degrees — a Master of Biomedical Science from Rutgers University, where I concentrated in stem cell biology, and an MBA from Villanova University specializing in artificial intelligence and machine learning. Before either of those, I studied Biology at Drexel and spent years in academic and pharmaceutical research.
For years I watched the pieces of a person's health sit in separate silos: DNA in one company's vault, bloodwork in a patient portal, medications at the pharmacy, supplements on the kitchen counter. No single service used today's AI to look at them together and produce something a physician could actually review. So I built one.
Then I ran my own file through it. I learned I carry DNA variants I can pass on to my sons — they're five and eight. Variants I never would have known to ask about.
And I learned something that stopped me cold: one of my daily prescription medications has two direct contraindications with two supplements I was already taking. Both are common. One is so ordinary you can buy it at any retail pharmacy — so ordinary it never occurred to me to even mention it to my primary care provider. There's no black-box warning. There's nothing on either bottle. The risk only became visible when my medications and my supplements were reviewed side by side.
MarkerView exists so you can find these things the way I did — before they matter, not after.